Structure–activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists
…, R Tamir, NR Gavva, JJS Treanor, MH Norman
Index: Gore, Vijay K.; Ma, Vu V.; Tamir, Rami; Gavva, Narender R.; Treanor, James J.S.; Norman, Mark H. Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 21 p. 5825 - 5830
Full Text: HTML
Citation Number: 26
Abstract
A novel series of 4, 5-biarylimidazoles as TRPV1 antagonists were designed based on the previously reported 4, 6-disubstituted benzimidazole series. The analogs were evaluated for their ability to block capsaicin-or acid-induced calcium influx in TRPV1-expressing CHO cells. These studies led to the identification of a highly potent and orally bioavailable TRPV1 antagonist, imidazole 33.
Related Articles:
[Schulz, Gisela L.; Mastalerz, Michael; Ma, Chang-Qi; Wienk, Martijn; Janssen, Rene; Baeuerle, Peter Macromolecules, 2013 , vol. 46, # 6 p. 2141 - 2151]
[Brana, Miguel F.; Cacho, Monica; Garcia, M. Luisa; Mayoral, Elena P.; Lopez, Berta; De Pascual-Teresa, Beatriz; Ramos, Ana; Acero, Nuria; Llinares, Francisco; Munoz-Mingarro, Dolores; Lozach, Olivier; Meijer, Laurent Journal of Medicinal Chemistry, 2005 , vol. 48, # 22 p. 6843 - 6854]
[Powell, Adam B.; Suzuki, Yasuo; Ueda, Mitsuru; Bielawski, Christopher W.; Cowley, Alan H. Journal of the American Chemical Society, 2011 , vol. 133, # 14 p. 5218 - 5220]
[Heintz, Monique; Devaud, Marguerite; Hebri, Hassan; Dunach, Elisabet; Troupel, Michel Tetrahedron, 1993 , vol. 49, # 11 p. 2249 - 2252]